INDRAPRASTHA MEDICAL Fact Sheet, INDRAPRASTHA MEDICAL Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Fact Sheet    (IRMED)


New Opportunity: India's #1 Defence Stock


Here is the latest financial fact sheet of INDRAPRASTHA MEDICAL. For more details, see the INDRAPRASTHA MEDICAL quarterly results and INDRAPRASTHA MEDICAL share price and chart. For a sector overview, read our pharmaceuticals sector report.

INDRAPRASTHA MEDICAL Price History

Price Rs 49.8
Mkt Cap Rs m 4,565
Vol '000 0.6
P/E X 10.5
P/CF X 7.8
EPS (TTM) Rs 4.8
% ch % 0.2
No. of shares m 91.67
% ch week % -1.1
% ch 1-mth % 3.4
% ch 12-mth % 40.1
52 week H/L Rs 65.0/27.5
(As on Oct 20, 2020 11:34:00 AM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

INDRAPRASTHA MEDICAL Financials

No. of Mths
Year Ending
12
Mar-15
12
Mar-16
12
Mar-17
12
Mar-18
12
Mar-19
5-Yr Chart
Click to enlarge
INDRAPRASTHA MEDICAL EQUITY SHARE DATA
High RsNA77636952 
Low RsNA47454636 
Sales per share (Unadj.) Rs77.982.683.582.186.0 
Earnings per share (Unadj.) Rs3.53.12.92.33.1 
Diluted earnings per shareRs3.53.12.92.33.1 
Cash flow per share (Unadj.) Rs6.66.06.25.66.3 
Dividends per share (Unadj.) Rs1.801.801.801.501.60 
Adj. dividends per shareRs1.801.801.801.501.60 
Dividend yield (eoy) %NM2.93.32.63.6 
Book value per share (Unadj.) Rs21.222.225.225.326.6 
Adj. book value per shareRs21.222.225.225.326.6 
Shares outstanding (eoy) m91.6791.6791.6791.6791.67 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x00.70.60.70.5 
Avg P/E ratio x020.118.924.914.2 
P/CF ratio (eoy) x010.38.810.27.0 
Price / Book Value ratio x02.82.22.31.7 
Dividend payout %50.858.462.965.151.6 
Avg Mkt Cap Rs m05,6704,9695,2624,043 
No. of employees `0003.23.23.03.03.0 
Total wages/salary Rs m1,5581,8031,9021,9402,002 
Avg. sales/employee Rs Th2,218.12,404.92,581.72,493.12,608.1 
Avg. wages/employee Rs Th483.7572.5641.3642.6662.5 
Avg. net profit/employee Rs Th100.989.688.569.994.0 
INDRAPRASTHA MEDICAL INCOME DATA
Net Sales Rs m7,1457,5757,6577,5277,882 
Other income Rs m1021585 
Total revenues Rs m7,1547,5967,6627,5357,886 
Gross profit Rs m849763788728808 
Depreciation Rs m282266305307298 
Interest Rs m8173798969 
Profit before tax Rs m496445408340446 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m171163146129162 
Profit after tax Rs m325282262211284 
Gross profit margin %11.910.110.39.710.2 
Effective tax rate %34.436.535.737.936.3 
Net profit margin %4.53.73.42.83.6 
INDRAPRASTHA MEDICAL BALANCE SHEET DATA
Current assets Rs m1,4881,7041,5791,3291,356 
Current liabilities Rs m1,9402,1691,8571,3841,241 
Net working cap to sales %-6.3-6.1-3.6-0.71.5 
Current ratio x0.80.80.91.01.1 
Inventory Days Days66544 
Debtors Days Days4044474135 
Net fixed assets Rs m2,8872,9603,0052,9402,814 
Share capital Rs m917917917917917 
"Free" reserves Rs m1,0311,1151,3921,4061,524 
Net worth Rs m1,9482,0312,3082,3232,440 
Long term debt Rs m108250210150 
Total assets Rs m4,4164,6644,5844,3234,224 
Interest coverage x7.17.16.24.87.5 
Debt to equity ratio x0.1000.10.1 
Sales to assets ratio x1.61.61.71.71.9 
Return on assets %9.27.67.56.98.4 
Return on equity %16.713.911.49.111.6 
Return on capital %28.025.221.116.919.9 
Exports to sales %00000 
Imports to sales %2.12.11.22.20 
Exports (fob) Rs m00000 
Imports (cif) Rs m148160931630 
Fx inflow Rs m01,0411,2581,5581,483 
Fx outflow Rs m148266289418149 
Net fx Rs m-1487759681,1401,334 
INDRAPRASTHA MEDICAL CASH FLOW
From Operations Rs m 643 620 276 477 752 
From Investments Rs m -291 -325 -224 -299 -167 
From Financial Activity Rs m -352 -300 -54 -172 -442 
Net Cashflow Rs m -1 -6 -2 6 143 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 49.4%
Foreign collaborators 1.6%
Indian inst/Mut Fund 1.3%
FIIs 0.5%
ADR/GDR 0.0%
Free float 47.2%
Shareholders 38,169
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Sarita Vihar, Delhi - Mathura Road, New Delhi - 110 076
E-MAIL asinghal@apollohospitals.com WEB www.apollohospdelhi.com
TELEPHONE (011) 2692 5858 FAX (011) 2682 5601
SECTOR HEALTH SERVICES GROUP MISCELLANEOUS
TR AGENT Link Intime India, 44, 2nd Flr., Naraina Indl. Area, Phase I, New Delhi-28
AUDITOR S. C. Vasudeva & Co.
CHM: S. K. Srivastava COMP SEC: A. K. Singhal YEAR OF INC: 1900 BSE CODE: 532150 FV (Rs): 10 DIV YIELD (%): 3.2

Read: INDRAPRASTHA MEDICAL 2018-19 Annual Report Analysis

More Health Services Company Fact Sheets:   AUROBINDO PHARMA  PANACEA BIOTECH  GSK PHARMA  ORCHID PHARMA  GLENMARK PHARMA  

Compare INDRAPRASTHA MEDICAL With:   AUROBINDO PHARMA  PANACEA BIOTECH  GSK PHARMA  ORCHID PHARMA  GLENMARK PHARMA  

Compare INDRAPRASTHA MEDICAL With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  




Today's Market

Sensex Opens Flat; Banking & FMCG Stocks Under Pressure(09:30 am)

Asian stock markets are lower today as investors adjusted risk exposure heading into the US election and as a deadline for Washington to pass an economic stimulus bill approached.

Views on news

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL 2018-19 Annual Report Analysis (Annual Result Update)

Oct 18, 2019 | Updated on Oct 18, 2019

Here's an analysis of the annual report of INDRAPRASTHA MEDICAL for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of INDRAPRASTHA MEDICAL. Also includes updates on the valuation of INDRAPRASTHA MEDICAL.

More Views on News

Most Popular

My Latest Stock Recommendation (Fast Profits Daily)

Oct 9, 2020

How I picked an exciting stock using trends from both the commodity and equity markets.

The 'Seedhi Baat, No Bakwaas' View on ITC (Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

How to Shortlist the Best Stocks for Trading (Fast Profits Daily)

Oct 7, 2020

In this video, I'll show you how to identify a confluence of factors in the market which will point you to the best stocks to trade.

The Inflection Point for Defence Stocks is Getting Closer (Profit Hunter)

Oct 9, 2020

Few Indian defence companies could use their engineering capabilities to eventually become global leaders.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL - FORTIS HEALTHCARE COMPARISON

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS